EMA's new executive director likely to take charge at end of 2011/early 2012
This article was originally published in SRA
Guido Rasi is not expected to take charge as the new executive director of the European Medicines Agency until late this year or early next year, an agency spokesperson has told Regulatory Affairs Pharma1.
You may also be interested in...
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
A first-of-its-kind collaborative study has found that real-world and natural history data are comparable to placebo data from clinical trials in Duchenne muscular dystrophy.
An EU group has listed several ambitious projects to help EU regulators realize their cherished vision of using big data capabilities to support innovation and public health. But these proposals may take a backseat as COVID-19-related challenges continue.